DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹8,397 Cr | ₹8,211 Cr | ₹7,156 Cr | ₹5,062 Cr | ₹3,753 Cr |
What is the latest Net Current Assets ratio of DIVIS LABORATORIES ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹8,397 Cr |
Mar2023 | ₹8,211 Cr |
Mar2022 | ₹7,156 Cr |
Mar2021 | ₹5,062 Cr |
Mar2020 | ₹3,753 Cr |
How is Net Current Assets of DIVIS LABORATORIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹8,397 Cr | 2.27 | |
Mar2023 | ₹8,211 Cr | 14.74 | |
Mar2022 | ₹7,156 Cr | 41.36 | |
Mar2021 | ₹5,062 Cr | 34.89 | |
Mar2020 | ₹3,753 Cr | - |
Compare Net Current Assets of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹152,628.0 Cr | -2.9% | -0.3% | 63.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,223.0 Cr | -4.1% | -9.8% | 8.2% | Stock Analytics | |
CIPLA | ₹119,067.0 Cr | 0.1% | 4.4% | 2.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹102,744.0 Cr | -1.3% | -6.5% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,123.8 Cr | -4% | -5.9% | -7.8% | Stock Analytics | |
MANKIND PHARMA | ₹95,998.8 Cr | -0.8% | -7.2% | 7.2% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.9% |
-0.3% |
63.8% |
SENSEX | -0.8% |
-1.6% |
3.1% |
You may also like the below Video Courses